Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

New BNF's authors defend errors

The number of “clinically important” errors in the updated text remains low, says the BNF team

The authors of the British National Formulary (BNF) have defended the number of errors in the updated version of the text.

The BNF team is aware of “a number of discussions and email threads” regarding the “small number of dose errors” that have been identified in the latest versions of the BNF and the BNF for Children, it said in a joint statement with UK Medicines Information (UKMI) and the Neonatal and Paediatric Pharmacists Group (NPPG).

The number of “clinically important errors identified to date remains low” in these versions, distributed to pharmacies last month, the organisations said last Friday (November 20).

It is “important to recognise” that errors were also reported in previous editions of the BNF, they stressed.

“As with any edition, other errors may still remain to be identified. Cross-checking with the updated electronic versions should be encouraged – this is particularly true for medicines less familiar to the practitioner,” the organisations said.

Some of the reported errors are “simply changes to the way content is represented” in the texts, the organisations added.

Publishing corrections

The BNF team is using its website to publish corrections to identified errors, such as the omission of intravenous doses for certain indications of the antiviral aciclovir.

BNF director Karen Baxter told C+D there is a “really low awareness” among BNF users that there has always been a process to identify and correct errors. “Although there are errors in both BNF[s], they are not occurring at a rate that’s markedly different from any previous editions,” she added.

The BNF team assess errors based on their risk of patient harm, Ms Baxter said. If a “really severe” error was error identifed, it would be corrected online “immediately”, she stressed.

Have you spotted any errors in the BNF?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel